We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Policy & Regulatory

Policy & Regulatory

Advocating for solutions and policies that help advance scientific innovation and ensure patients have access to the medicines they need.

© 2022 Genentech, Inc. All rights reserved. This site is intended for US residents only.